title: Aspirin for Primary Prevention of Cardiovascular Diseases: Current Concepts, Unanswered Questions and Future Directions.
authors.affiliation: Hospital Universitario Celestino Hernández Robau, Santa Clara, Villa Clara, Cuba.
authors.forename: Yaniel
authors.initials: Y
authors.lastname: Castro-Torres
authors.forename: Richard E
authors.initials: RE
authors.lastname: Katholi
authors.forename: Nabeel
authors.initials: N
authors.lastname: Yar Khan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000453:epidemiology / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin